发布求助
文献互助 智能选刊 最新文献

Pitting the FDA Against CMS: The good, the bad, and the ugly about "parallel review.".

Biotechnology healthcare Pub Date : 2011-01-01
Stephen Barlas
{"title":"Pitting the FDA Against CMS: The good, the bad, and the ugly about \"parallel review.\".","authors":"Stephen Barlas","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>The good, the bad, and the ugly about the FDA/CMS parallel review process. Can it work?</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"8 3","pages":"29-30"},"PeriodicalIF":0.0000,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3278123/pdf/bh0803029.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biotechnology healthcare","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The good, the bad, and the ugly about the FDA/CMS parallel review process. Can it work?

分享
本刊更多论文
让FDA对抗CMS:“平行审查”的好、坏和丑陋。
FDA/CMS平行审查过程的优点、缺点和缺点。它能起作用吗?
本文章由计算机程序翻译，如有差异，请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biotechnology healthcare
Biotechnology healthcare
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信